仙乐健康 - Financials

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	4.2B	3.6B	2.5B	2.4B	2.1B
Revenue Growth %	17.6%	42.9%	5.8%	14.6%	--
Total Revenue	4.2B	3.6B	2.5B	2.4B	2.1B
Cost Of Revenue	2.9B	2.5B	1.7B	1.6B	1.4B
+Gross Profit	1.3B	1.1B	781.0M	775.0M	674.0M
Gross Margin %	31.5%	30.3%	31.2%	32.7%	32.6%
Total Operating Cost	3.9B	3.3B	2.3B	2.1B	1.8B
Selling Expenses	353.0M	278.0M	130.0M	149.0M	122.0M
Admin Expenses	418.0M	351.0M	304.0M	245.0M	194.0M
Rd Expenses	126.0M	110.0M	80.7M	83.2M	64.7M
Finance Expenses	79.6M	52.3M	7.2M	26.3M	3.2M
+Operating Income	327.0M	282.0M	265.0M	290.0M	316.0M
Operating Margin %	7.8%	7.9%	10.6%	12.2%	15.3%
Non Operating Income	1.9M	1.4M	848,800	2.0M	924,700
Non Operating Expenses	12.3M	10.1M	14.4M	10.9M	4.6M
Investment Income	-4.8M	2.2M	23.4M	25.2M	16.2M
Fair Value Change Income	-21.9M	-57.7M	-1.6M	-1.0M	4.0M
Asset Disposal Income	243,200	34,000	143,900	153,000	-6,900
Asset Impairment Loss	5.1M	-405,400	5.0M	2.1M	2.6M
Other Income	41.9M	71.8M	7.7M	10.8M	24.8M
Income Before Tax	317.0M	273.0M	252.0M	281.0M	312.0M
Income Tax	34.6M	33.0M	39.2M	49.1M	54.6M
+Net Income	282.0M	240.0M	212.0M	232.0M	257.0M
Net Margin %	6.7%	6.7%	8.5%	9.8%	12.4%
Net Income Attributable	325.0M	281.0M	212.0M	232.0M	257.0M
Minority Interest	-43.0M	-40.8M	--	--	--
Eps Basic	1.39	1.20	1.18	1.29	1.43
Eps Diluted	1.39	1.20	1.17	1.22	1.42

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	636.0M	534.0M	1.5B	716.0M	217.0M
Trading Financial Assets	115.0M	201.0M	79.1M	531.0M	473.0M
Accounts Receivable	675.0M	613.0M	460.0M	342.0M	261.0M
Notes Receivable	12.2M	8.5M	--	--	--
Notes And Accounts Receivable	687.0M	621.0M	460.0M	342.0M	261.0M
Prepayments	20.9M	12.1M	16.4M	12.4M	23.3M
Inventory	482.0M	481.0M	233.0M	240.0M	267.0M
Total Current Assets	2.0B	1.9B	2.4B	1.9B	1.3B
Fixed Assets	--	1.4B	1.2B	786.0M	650.0M
Fixed Assets Total	1.5B	1.4B	1.2B	786.0M	650.0M
Construction In Progress	--	187.0M	69.3M	365.0M	118.0M
Construction In Progress Total	238.0M	187.0M	69.3M	365.0M	118.0M
Intangible Assets	526.0M	545.0M	178.0M	161.0M	129.0M
Long Term Deferred Expenses	226.0M	169.0M	20.9M	5.6M	1.9M
Total Non Current Assets	3.5B	3.3B	1.8B	1.9B	1.3B
Total Assets	5.5B	5.2B	4.2B	3.8B	2.6B
Short Term Borrowings	54.8M	--	155,700	116,900	1.6M
Accounts Payable	392.0M	392.0M	259.0M	196.0M	200.0M
Advance Receipts	--	--	--	--	--
Contract Liabilities	36.9M	53.1M	25.8M	28.2M	43.1M
Total Current Liabilities	825.0M	751.0M	470.0M	332.0M	387.0M
Long Term Borrowings	132.0M	82.9M	--	--	--
Total Non Current Liabilities	2.0B	1.9B	1.0B	943.0M	79.9M
Total Liabilities	2.8B	2.6B	1.5B	1.3B	467.0M
Paid In Capital	236.0M	182.0M	180.0M	180.0M	120.0M
Capital Reserve	501.0M	548.0M	1.0B	1.0B	1.1B
Surplus Reserve	108.0M	82.3M	71.1M	66.8M	56.3M
Retained Earnings	1.5B	1.4B	1.2B	1.1B	922.0M
Minority Equity	135.0M	176.0M	--	--	--
Equity Attributable	2.5B	2.4B	2.7B	2.5B	2.2B
Total Equity	2.6B	2.6B	2.7B	2.5B	2.2B

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	4.4B	3.4B	2.6B	2.4B	2.1B
Tax Refunds Received	57.7M	43.6M	85.7M	26.7M	30.3M
Total Operating Cash Inflow	4.4B	3.5B	2.7B	2.5B	2.2B
Cash Paid For Goods	2.6B	1.9B	1.6B	1.4B	1.3B
Cash Paid To Employees	850.0M	726.0M	411.0M	419.0M	330.0M
Taxes Paid	125.0M	132.0M	94.9M	112.0M	59.1M
Total Operating Cash Outflow	3.9B	3.1B	2.3B	2.1B	1.8B
Operating Cash Flow	567.0M	386.0M	445.0M	341.0M	320.0M
Total Investing Cash Inflow	509.0M	684.0M	2.9B	1.4B	448.0M
Total Investing Cash Outflow	837.0M	1.8B	2.6B	2.1B	843.0M
Investing Cash Flow	-328.0M	-1.2B	284.0M	-735.0M	-395.0M
Cash From Borrowings	271.0M	97.2M	33,900	1.0B	18.6M
Dividends And Interest Paid	220.0M	83.8M	76.1M	72.5M	25.9M
Debt Repayments	149.0M	155,700	--	31.9M	83.4M
Total Financing Cash Inflow	285.0M	114.0M	7.6M	1.0B	18.6M
Total Financing Cash Outflow	416.0M	205.0M	85.5M	113.0M	111.0M
Financing Cash Flow	-131.0M	-91.1M	-77.9M	906.0M	-92.9M
Net Change In Cash	111.0M	-868.0M	681.0M	501.0M	-180.0M
Ending Cash Balance	633.0M	522.0M	1.4B	709.0M	208.0M
Capex	412.0M	452.0M	294.0M	525.0M	223.0M